doi: 10.1128/JVI.64.3.1402-1406.1990.
Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence
Affiliations
- PMID: 2406460
- PMCID: PMC249266
- DOI: 10.1128/JVI.64.3.1402-1406.1990
Item in Clipboard
Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence
J Virol.
1990 Mar.
Abstract
In order to elucidate the molecular mechanisms of action of the tat-responsive sequence, mutational analysis of the tat-responsive sequence was carried out. The most critical region comprised nucleotides +18 to +44 and included the 3-nucleotide bulge at positions +23 to +25, the loop sequence, and an intact stem. In addition, base pairing up to nucleotide +52 was required for the full magnitude of the trans-activation response. Single-nucleotide bulges at positions +5 to +17 were dispensable. Analysis of truncated and full-length transcripts demonstrated that a transcriptional antitermination model does not fully account for trans activation.
Similar articles
-
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.Proc Natl Acad Sci U S A. 1990 Jul;87(13):5079-83. doi: 10.1073/pnas.87.13.5079. Proc Natl Acad Sci U S A. 1990. PMID: 2195547 Free PMC article.
-
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.Genes Dev. 1990 Aug;4(8):1365-73. doi: 10.1101/gad.4.8.1365. Genes Dev. 1990. PMID: 2227414
-
Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.J Virol. 1991 Oct;65(10):5196-202. doi: 10.1128/JVI.65.10.5196-5202.1991. J Virol. 1991. PMID: 1895380 Free PMC article.
-
RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.Biochemistry (Mosc). 1998 May;63(5):489-503. Biochemistry (Mosc). 1998. PMID: 9632883 Review.
-
Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.Arch Biochem Biophys. 1999 May 15;365(2):175-85. doi: 10.1006/abbi.1999.1206. Arch Biochem Biophys. 1999. PMID: 10328810 Review.
Cited by
-
Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.J Virol. 1992 Jun;66(6):3932-6. doi: 10.1128/JVI.66.6.3932-3936.1992. J Virol. 1992. PMID: 1583736 Free PMC article.
-
Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter.J Virol. 1991 May;65(5):2299-307. doi: 10.1128/JVI.65.5.2299-2307.1991. J Virol. 1991. PMID: 1850012 Free PMC article.
-
Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9734-8. doi: 10.1073/pnas.89.20.9734. Proc Natl Acad Sci U S A. 1992. PMID: 1409690 Free PMC article.
-
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.Microbiol Rev. 1995 Sep;59(3):481-505. doi: 10.1128/mr.59.3.481-505.1995. Microbiol Rev. 1995. PMID: 7565415 Free PMC article. Review.
-
A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.Nucleic Acids Res. 1996 Oct 1;24(19):3733-8. doi: 10.1093/nar/24.19.3733. Nucleic Acids Res. 1996. PMID: 8871552 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
